Fluorine in PDB 7uao: Structure of Human Endothelial Nitric Oxide Synthase Heme Domain in Complex with (6-(3-(4,4-Difluoropiperidin-1-Yl)Propyl)-4- Methylpyridin-2-Amine)
Enzymatic activity of Structure of Human Endothelial Nitric Oxide Synthase Heme Domain in Complex with (6-(3-(4,4-Difluoropiperidin-1-Yl)Propyl)-4- Methylpyridin-2-Amine)
All present enzymatic activity of Structure of Human Endothelial Nitric Oxide Synthase Heme Domain in Complex with (6-(3-(4,4-Difluoropiperidin-1-Yl)Propyl)-4- Methylpyridin-2-Amine):
1.14.13.39;
Protein crystallography data
The structure of Structure of Human Endothelial Nitric Oxide Synthase Heme Domain in Complex with (6-(3-(4,4-Difluoropiperidin-1-Yl)Propyl)-4- Methylpyridin-2-Amine), PDB code: 7uao
was solved by
H.Li,
T.L.Poulos,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
39.06 /
1.90
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
59.488,
152.846,
108.741,
90,
90.75,
90
|
R / Rfree (%)
|
20.1 /
24.6
|
Other elements in 7uao:
The structure of Structure of Human Endothelial Nitric Oxide Synthase Heme Domain in Complex with (6-(3-(4,4-Difluoropiperidin-1-Yl)Propyl)-4- Methylpyridin-2-Amine) also contains other interesting chemical elements:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Structure of Human Endothelial Nitric Oxide Synthase Heme Domain in Complex with (6-(3-(4,4-Difluoropiperidin-1-Yl)Propyl)-4- Methylpyridin-2-Amine)
(pdb code 7uao). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 8 binding sites of Fluorine where determined in the
Structure of Human Endothelial Nitric Oxide Synthase Heme Domain in Complex with (6-(3-(4,4-Difluoropiperidin-1-Yl)Propyl)-4- Methylpyridin-2-Amine), PDB code: 7uao:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
7;
8;
Fluorine binding site 1 out
of 8 in 7uao
Go back to
Fluorine Binding Sites List in 7uao
Fluorine binding site 1 out
of 8 in the Structure of Human Endothelial Nitric Oxide Synthase Heme Domain in Complex with (6-(3-(4,4-Difluoropiperidin-1-Yl)Propyl)-4- Methylpyridin-2-Amine)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Structure of Human Endothelial Nitric Oxide Synthase Heme Domain in Complex with (6-(3-(4,4-Difluoropiperidin-1-Yl)Propyl)-4- Methylpyridin-2-Amine) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F503
b:108.8
occ:1.00
|
F17
|
A:M5L503
|
0.0
|
108.8
|
1.0
|
C14
|
A:M5L503
|
1.3
|
104.6
|
1.0
|
F18
|
A:M5L503
|
2.2
|
107.6
|
1.0
|
C15
|
A:M5L503
|
2.3
|
98.4
|
1.0
|
C13
|
A:M5L503
|
2.3
|
97.7
|
1.0
|
C16
|
A:M5L503
|
2.9
|
89.8
|
1.0
|
C12
|
A:M5L503
|
2.9
|
90.5
|
1.0
|
N11
|
A:M5L503
|
3.5
|
84.3
|
1.0
|
ND2
|
A:ASN338
|
3.6
|
73.0
|
1.0
|
OD1
|
A:ASN338
|
4.0
|
69.8
|
1.0
|
CB
|
A:SER246
|
4.1
|
56.3
|
1.0
|
CG
|
A:ASN338
|
4.2
|
68.5
|
1.0
|
OG
|
A:SER246
|
4.6
|
68.9
|
1.0
|
C10
|
A:M5L503
|
4.6
|
69.9
|
1.0
|
O
|
A:SER246
|
4.9
|
52.9
|
1.0
|
|
Fluorine binding site 2 out
of 8 in 7uao
Go back to
Fluorine Binding Sites List in 7uao
Fluorine binding site 2 out
of 8 in the Structure of Human Endothelial Nitric Oxide Synthase Heme Domain in Complex with (6-(3-(4,4-Difluoropiperidin-1-Yl)Propyl)-4- Methylpyridin-2-Amine)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Structure of Human Endothelial Nitric Oxide Synthase Heme Domain in Complex with (6-(3-(4,4-Difluoropiperidin-1-Yl)Propyl)-4- Methylpyridin-2-Amine) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F503
b:107.6
occ:1.00
|
F18
|
A:M5L503
|
0.0
|
107.6
|
1.0
|
C14
|
A:M5L503
|
1.3
|
104.6
|
1.0
|
F17
|
A:M5L503
|
2.2
|
108.8
|
1.0
|
C13
|
A:M5L503
|
2.3
|
97.7
|
1.0
|
C15
|
A:M5L503
|
2.3
|
98.4
|
1.0
|
ND2
|
A:ASN338
|
3.6
|
73.0
|
1.0
|
C12
|
A:M5L503
|
3.7
|
90.5
|
1.0
|
C16
|
A:M5L503
|
3.7
|
89.8
|
1.0
|
OD1
|
A:ASN338
|
4.0
|
69.8
|
1.0
|
O2D
|
A:HEM501
|
4.1
|
67.8
|
1.0
|
N11
|
A:M5L503
|
4.1
|
84.3
|
1.0
|
CE1
|
A:TYR475
|
4.1
|
61.0
|
1.0
|
CG
|
A:ASN338
|
4.2
|
68.5
|
1.0
|
CD1
|
A:TYR475
|
4.3
|
55.3
|
1.0
|
O
|
A:HOH703
|
4.4
|
54.4
|
1.0
|
CZ
|
A:PHE105
|
4.6
|
68.7
|
1.0
|
CE2
|
A:PHE105
|
4.6
|
69.0
|
1.0
|
O
|
A:HOH663
|
4.9
|
51.6
|
1.0
|
|
Fluorine binding site 3 out
of 8 in 7uao
Go back to
Fluorine Binding Sites List in 7uao
Fluorine binding site 3 out
of 8 in the Structure of Human Endothelial Nitric Oxide Synthase Heme Domain in Complex with (6-(3-(4,4-Difluoropiperidin-1-Yl)Propyl)-4- Methylpyridin-2-Amine)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Structure of Human Endothelial Nitric Oxide Synthase Heme Domain in Complex with (6-(3-(4,4-Difluoropiperidin-1-Yl)Propyl)-4- Methylpyridin-2-Amine) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F503
b:74.8
occ:1.00
|
F17
|
B:M5L503
|
0.0
|
74.8
|
1.0
|
C14
|
B:M5L503
|
1.3
|
73.7
|
1.0
|
F18
|
B:M5L503
|
2.2
|
71.9
|
1.0
|
C15
|
B:M5L503
|
2.3
|
71.2
|
1.0
|
C13
|
B:M5L503
|
2.4
|
50.0
|
1.0
|
O
|
B:HOH703
|
2.5
|
51.7
|
1.0
|
C16
|
B:M5L503
|
2.9
|
65.0
|
1.0
|
C12
|
B:M5L503
|
3.0
|
54.1
|
1.0
|
O
|
B:HOH715
|
3.2
|
51.0
|
1.0
|
N11
|
B:M5L503
|
3.5
|
52.4
|
1.0
|
ND2
|
B:ASN338
|
3.8
|
48.2
|
1.0
|
OD1
|
B:ASN338
|
4.0
|
38.0
|
1.0
|
CG
|
B:ASN338
|
4.3
|
34.9
|
1.0
|
C10
|
B:M5L503
|
4.5
|
49.7
|
1.0
|
CB
|
B:SER246
|
4.7
|
35.5
|
1.0
|
O2D
|
B:HEM501
|
4.7
|
54.6
|
1.0
|
O
|
B:HOH767
|
4.9
|
53.6
|
1.0
|
|
Fluorine binding site 4 out
of 8 in 7uao
Go back to
Fluorine Binding Sites List in 7uao
Fluorine binding site 4 out
of 8 in the Structure of Human Endothelial Nitric Oxide Synthase Heme Domain in Complex with (6-(3-(4,4-Difluoropiperidin-1-Yl)Propyl)-4- Methylpyridin-2-Amine)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Structure of Human Endothelial Nitric Oxide Synthase Heme Domain in Complex with (6-(3-(4,4-Difluoropiperidin-1-Yl)Propyl)-4- Methylpyridin-2-Amine) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F503
b:71.9
occ:1.00
|
F18
|
B:M5L503
|
0.0
|
71.9
|
1.0
|
C14
|
B:M5L503
|
1.3
|
73.7
|
1.0
|
F17
|
B:M5L503
|
2.2
|
74.8
|
1.0
|
C13
|
B:M5L503
|
2.3
|
50.0
|
1.0
|
C15
|
B:M5L503
|
2.3
|
71.2
|
1.0
|
CE1
|
B:TYR475
|
3.4
|
43.1
|
1.0
|
O
|
B:HOH767
|
3.7
|
53.6
|
1.0
|
C16
|
B:M5L503
|
3.7
|
65.0
|
1.0
|
C12
|
B:M5L503
|
3.7
|
54.1
|
1.0
|
O2D
|
B:HEM501
|
3.7
|
54.6
|
1.0
|
CD1
|
B:TYR475
|
3.8
|
38.6
|
1.0
|
ND2
|
B:ASN338
|
4.2
|
48.2
|
1.0
|
N11
|
B:M5L503
|
4.2
|
52.4
|
1.0
|
O
|
B:HOH703
|
4.3
|
51.7
|
1.0
|
OD1
|
B:ASN338
|
4.3
|
38.0
|
1.0
|
CZ
|
B:TYR475
|
4.4
|
46.3
|
1.0
|
CE1
|
B:PHE105
|
4.4
|
45.5
|
1.0
|
CZ
|
B:PHE105
|
4.5
|
44.6
|
1.0
|
CG
|
B:ASN338
|
4.7
|
34.9
|
1.0
|
OH
|
B:TYR475
|
4.7
|
57.5
|
1.0
|
CGD
|
B:HEM501
|
4.7
|
47.0
|
1.0
|
O
|
B:HOH630
|
4.8
|
41.2
|
1.0
|
|
Fluorine binding site 5 out
of 8 in 7uao
Go back to
Fluorine Binding Sites List in 7uao
Fluorine binding site 5 out
of 8 in the Structure of Human Endothelial Nitric Oxide Synthase Heme Domain in Complex with (6-(3-(4,4-Difluoropiperidin-1-Yl)Propyl)-4- Methylpyridin-2-Amine)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Structure of Human Endothelial Nitric Oxide Synthase Heme Domain in Complex with (6-(3-(4,4-Difluoropiperidin-1-Yl)Propyl)-4- Methylpyridin-2-Amine) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:F503
b:91.5
occ:1.00
|
F17
|
C:M5L503
|
0.0
|
91.5
|
1.0
|
C14
|
C:M5L503
|
1.3
|
91.1
|
1.0
|
F18
|
C:M5L503
|
2.2
|
92.4
|
1.0
|
C15
|
C:M5L503
|
2.3
|
88.1
|
1.0
|
C13
|
C:M5L503
|
2.3
|
92.0
|
1.0
|
C16
|
C:M5L503
|
2.9
|
88.1
|
1.0
|
C12
|
C:M5L503
|
3.0
|
85.5
|
1.0
|
ND2
|
C:ASN338
|
3.4
|
61.6
|
1.0
|
N11
|
C:M5L503
|
3.5
|
79.0
|
1.0
|
OD1
|
C:ASN338
|
3.8
|
56.2
|
1.0
|
CG
|
C:ASN338
|
4.0
|
53.3
|
1.0
|
CB
|
C:SER246
|
4.5
|
46.0
|
1.0
|
C10
|
C:M5L503
|
4.6
|
68.5
|
1.0
|
O2D
|
C:HEM501
|
4.7
|
74.2
|
1.0
|
|
Fluorine binding site 6 out
of 8 in 7uao
Go back to
Fluorine Binding Sites List in 7uao
Fluorine binding site 6 out
of 8 in the Structure of Human Endothelial Nitric Oxide Synthase Heme Domain in Complex with (6-(3-(4,4-Difluoropiperidin-1-Yl)Propyl)-4- Methylpyridin-2-Amine)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of Structure of Human Endothelial Nitric Oxide Synthase Heme Domain in Complex with (6-(3-(4,4-Difluoropiperidin-1-Yl)Propyl)-4- Methylpyridin-2-Amine) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:F503
b:92.4
occ:1.00
|
F18
|
C:M5L503
|
0.0
|
92.4
|
1.0
|
C14
|
C:M5L503
|
1.3
|
91.1
|
1.0
|
F17
|
C:M5L503
|
2.2
|
91.5
|
1.0
|
C15
|
C:M5L503
|
2.3
|
88.1
|
1.0
|
C13
|
C:M5L503
|
2.3
|
92.0
|
1.0
|
C16
|
C:M5L503
|
3.7
|
88.1
|
1.0
|
OD1
|
C:ASN338
|
3.7
|
56.2
|
1.0
|
C12
|
C:M5L503
|
3.7
|
85.5
|
1.0
|
ND2
|
C:ASN338
|
3.7
|
61.6
|
1.0
|
CE1
|
C:TYR475
|
3.8
|
55.6
|
1.0
|
O2D
|
C:HEM501
|
3.9
|
74.2
|
1.0
|
CD1
|
C:TYR475
|
3.9
|
50.4
|
1.0
|
CG
|
C:ASN338
|
4.1
|
53.3
|
1.0
|
N11
|
C:M5L503
|
4.1
|
79.0
|
1.0
|
O
|
C:HOH623
|
4.6
|
42.7
|
1.0
|
CZ
|
C:PHE105
|
4.6
|
64.1
|
1.0
|
CE2
|
C:PHE105
|
4.7
|
60.5
|
1.0
|
CG
|
C:MET339
|
4.8
|
45.2
|
1.0
|
CZ
|
C:TYR475
|
5.0
|
53.7
|
1.0
|
|
Fluorine binding site 7 out
of 8 in 7uao
Go back to
Fluorine Binding Sites List in 7uao
Fluorine binding site 7 out
of 8 in the Structure of Human Endothelial Nitric Oxide Synthase Heme Domain in Complex with (6-(3-(4,4-Difluoropiperidin-1-Yl)Propyl)-4- Methylpyridin-2-Amine)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 7 of Structure of Human Endothelial Nitric Oxide Synthase Heme Domain in Complex with (6-(3-(4,4-Difluoropiperidin-1-Yl)Propyl)-4- Methylpyridin-2-Amine) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:F503
b:91.3
occ:1.00
|
F17
|
D:M5L503
|
0.0
|
91.3
|
1.0
|
C14
|
D:M5L503
|
1.3
|
85.8
|
1.0
|
F18
|
D:M5L503
|
2.2
|
88.7
|
1.0
|
C15
|
D:M5L503
|
2.3
|
79.4
|
1.0
|
C13
|
D:M5L503
|
2.3
|
77.9
|
1.0
|
C16
|
D:M5L503
|
2.8
|
80.1
|
1.0
|
C12
|
D:M5L503
|
2.9
|
74.2
|
1.0
|
O
|
D:HOH735
|
3.2
|
40.6
|
1.0
|
N11
|
D:M5L503
|
3.4
|
68.2
|
1.0
|
ND2
|
D:ASN338
|
3.8
|
45.3
|
1.0
|
OD1
|
D:ASN338
|
4.1
|
39.0
|
1.0
|
CG
|
D:ASN338
|
4.4
|
33.1
|
1.0
|
C10
|
D:M5L503
|
4.5
|
52.3
|
1.0
|
CB
|
D:SER246
|
4.7
|
39.8
|
1.0
|
O2D
|
D:HEM501
|
4.8
|
73.1
|
1.0
|
|
Fluorine binding site 8 out
of 8 in 7uao
Go back to
Fluorine Binding Sites List in 7uao
Fluorine binding site 8 out
of 8 in the Structure of Human Endothelial Nitric Oxide Synthase Heme Domain in Complex with (6-(3-(4,4-Difluoropiperidin-1-Yl)Propyl)-4- Methylpyridin-2-Amine)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 8 of Structure of Human Endothelial Nitric Oxide Synthase Heme Domain in Complex with (6-(3-(4,4-Difluoropiperidin-1-Yl)Propyl)-4- Methylpyridin-2-Amine) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:F503
b:88.7
occ:1.00
|
F18
|
D:M5L503
|
0.0
|
88.7
|
1.0
|
C14
|
D:M5L503
|
1.3
|
85.8
|
1.0
|
F17
|
D:M5L503
|
2.2
|
91.3
|
1.0
|
C15
|
D:M5L503
|
2.3
|
79.4
|
1.0
|
C13
|
D:M5L503
|
2.4
|
77.9
|
1.0
|
CE1
|
D:TYR475
|
3.5
|
43.9
|
1.0
|
C16
|
D:M5L503
|
3.6
|
80.1
|
1.0
|
C12
|
D:M5L503
|
3.7
|
74.2
|
1.0
|
CD1
|
D:TYR475
|
3.9
|
36.3
|
1.0
|
O2D
|
D:HEM501
|
4.0
|
73.1
|
1.0
|
ND2
|
D:ASN338
|
4.1
|
45.3
|
1.0
|
N11
|
D:M5L503
|
4.1
|
68.2
|
1.0
|
OD1
|
D:ASN338
|
4.3
|
39.0
|
1.0
|
CZ
|
D:TYR475
|
4.6
|
49.5
|
1.0
|
CGD
|
D:HEM501
|
4.6
|
64.6
|
1.0
|
CG
|
D:ASN338
|
4.6
|
33.1
|
1.0
|
CE1
|
D:PHE105
|
4.7
|
51.6
|
1.0
|
CZ
|
D:PHE105
|
4.7
|
45.6
|
1.0
|
O
|
D:HOH724
|
4.9
|
34.6
|
1.0
|
CG
|
D:MET339
|
4.9
|
32.6
|
1.0
|
O1D
|
D:HEM501
|
4.9
|
66.6
|
1.0
|
OH
|
D:TYR475
|
5.0
|
48.8
|
1.0
|
|
Reference:
D.Vasu,
H.Li,
C.D.Hardy,
T.L.Poulos,
R.B.Silverman.
2-Aminopyridines with A Shortened Amino Sidechain As Potent, Selective, and Highly Permeable Human Neuronal Nitric Oxide Synthase Inhibitors. Bioorg.Med.Chem. V. 69 16878 2022.
ISSN: ESSN 1464-3391
PubMed: 35772285
DOI: 10.1016/J.BMC.2022.116878
Page generated: Fri Aug 2 14:00:51 2024
|